10 news items
Zomedica Enhances TRUFORMA(R) Platform With Launch of Advanced Canine Cortisol Assay
ZOM
29 May 24
protection, risks related to the COVID-19 pandemic and its impact upon our business operations generally, including our ability to develop and commercialize
Zomedica Publishes White Paper Highlighting Expanded Market Opportunities for PulseVet(R) Therapy
ZOM
23 May 24
, risks related to the COVID-19 pandemic and its impact upon our business operations generally, including our ability to develop and commercialize our
Zomedica Releases Over-the-Air Software Update Capabilities for Its TRUFORMA(R) Platform
ZOM
15 May 24
to the COVID-19 pandemic and its impact upon our business operations generally, including our ability to develop and commercialize our products
Zomedica Announces First Quarter 2024 Financial Results: Revenue up 14% to $6.3 Million; 66% Gross Margin, and $91 Million in Liquidity
ZOM
9 May 24
, intellectual property protection, risks related to the COVID-19 pandemic and its impact upon our business operations generally, including our ability
Zomedica Expands International Reach with CE Certification for VetGuardian(R) System
ZOM
6 May 24
, intellectual property protection, risks related to the COVID-19 pandemic and its impact upon our business operations generally, including our ability
1312pug kp
ZOM
2 May 24
, the use of our products, intellectual property protection, risks related to the COVID-19 pandemic and its impact upon our business operations
7bx4p59sff5561g521dfk9qu9ujdnbnx46s1vwlmfrptcqsm8 bzwa
ZOM
14 Mar 24
to the COVID-19 pandemic and its impact upon our business operations generally, including our ability to develop and commercialize our products, and the other
3bw swtkfvy
ZOM
13 Mar 24
relating to the safety and efficacy of our products, the use of our products, intellectual property protection, risks related to the COVID-19 pandemic
snuvckz z4fkb9io1yb
ZOM
12 Mar 24
-19 pandemic and its impact upon our business operations generally, including our ability to develop and commercialize our products, and the other risk
9kwvs4
ZOM
7 Mar 24
, intellectual property protection, risks related to the COVID-19 pandemic and its impact upon our business operations generally, including our ability to develop
- Prev
- 1
- Next